Abstract
BackgroundIron-deficiency anemia during pregnancy is an underlying cause of maternal deaths, and reducing risk through routine iron supplementation is a key component of antenatal care (ANC) programs in most low- and middle income countries. Supplementation coverage during pregnancy is estimated from maternal self-reports in population-based household surveys, yet recall bias and social desirability bias lead to errors of unknown magnitude.MethodsWe linked data from household and health facility surveys from 16 countries to estimate input-adjusted coverage of iron supplementation during pregnancy. We assessed the validity of reported receipt of iron supplements in client exit interviews using direct observation as the gold standard across 9 countries with a recent Service Provision Assessment (SPA). Using a sample of 227 women who participated in the Nepal Oil Massage Study (NOMS), we also assessed the validity of self-reported receipt of iron folic acid (IFA) supplements. We used Poisson regression models to explore the association between client and health facility characteristics and agreement of self-reported receipt of iron supplements compared to direct observation.ResultsAcross the 16 countries, iron supplements were in supply at most of the 9215 sampled health facilities offering ANC services (91%). We estimated that between 48 and 93% of women attended at least one ANC visit at a health facility with iron supplements available. The specificity of recall of receipt of iron supplementation immediately following a visit was 79.3% and the sensitivity was 88.7% for the entire sample. Individual-level accuracy was high (Area under the curve > 0.7) and population bias low (0.75 < inflation factor < 1.25) across all countries. By contrast, in the NOMS sub-study, the accuracy of self-reported receipt of IFA supplements after 1–2 years was poor (sensitivity 86.1%, specificity 34.3%). Adjusted regression analyses indicated that older age and higher level of education were associated with poorer agreement between self-reports and direct observation.ConclusionsThese findings suggest the need for caution when using self-reported measures with an extended recall period. Further validation studies using conditions similar to widely used population-based household surveys are warranted.
Highlights
Iron-deficiency anemia during pregnancy is an underlying cause of maternal deaths, and reducing risk through routine iron supplementation is a key component of antenatal care (ANC) programs in most low- and middle income countries
Iron and folic acid (IFA) supplementation during pregnancy is a low-cost and effective method to reduce the burden of maternal anemia, sepsis, low birth weight, and preterm birth [3,4,5]
Estimation of input-adjusted coverage Of 11,013 facilities sampled in the 16 countries between 2007 and 2016, 9215 reported offering ANC services and were included in the analysis (Table 2)
Summary
Iron-deficiency anemia during pregnancy is an underlying cause of maternal deaths, and reducing risk through routine iron supplementation is a key component of antenatal care (ANC) programs in most low- and middle income countries. Iron and folic acid (IFA) supplementation during pregnancy is a low-cost and effective method to reduce the burden of maternal anemia, sepsis, low birth weight, and preterm birth [3,4,5]. The World Health Organization (WHO) recommends daily supplementation with 30-60 mg of elemental iron and 0.4 mg of folic acid starting as early as possible in pregnancy [5]. Provision of iron supplements during pregnancy to prevent maternal anemia has been implemented extensively in antenatal care (ANC) programs across lowand middle-income countries (LMICs). Recent data from 36 LMICs suggest that less than one third (30%) of mothers consumed IFA supplements for 90 or more days during pregnancy [6]
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have